BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hegade VS, Bolier R, Oude Elferink RP, Beuers U, Kendrick S, Jones DE. A systematic approach to the management of cholestatic pruritus in primary biliary cirrhosis. Frontline Gastroenterol 2016;7:158-66. [PMID: 28839853 DOI: 10.1136/flgastro-2015-100618] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Younossi ZM, Bernstein D, Shiffman ML, Kwo P, Kim WR, Kowdley KV, Jacobson IM. Diagnosis and Management of Primary Biliary Cholangitis. Am J Gastroenterol 2019;114:48-63. [DOI: 10.1038/s41395-018-0390-3] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 8.7] [Reference Citation Analysis]
2 Khanna A, Leighton J, Lee Wong L, Jones DE. Symptoms of PBC – Pathophysiology and management. Best Practice & Research Clinical Gastroenterology 2018;34-35:41-7. [DOI: 10.1016/j.bpg.2018.06.007] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
3 Lee MK, Chung WJ. Relationship between symptoms and both stage of change in adopting a healthy life style and quality of life in patients with liver cirrhosis: a cross-sectional study. Health Qual Life Outcomes 2021;19:148. [PMID: 34001156 DOI: 10.1186/s12955-021-01787-9] [Reference Citation Analysis]
4 Azoulay D, Feray C, Lim C, Salloum C, Conticchio M, Cherqui D, Sa Cunha A, Adam R, Vibert E, Samuel D, Allard MA, Golse N. A systematic review of auxiliary liver transplantation of small for size grafts in patients with chronic liver disease. JHEP Reports 2022. [DOI: 10.1016/j.jhepr.2022.100447] [Reference Citation Analysis]
5 Ino H, Endo A, Wakamatsu A, Ogura H, Numachi Y, Kendrick S. Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Evaluations Following Single Oral Doses of GSK2330672 in Healthy Japanese Volunteers. Clin Pharmacol Drug Dev 2019;8:70-7. [PMID: 29870578 DOI: 10.1002/cpdd.576] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Wetten A, Jones DEJ, Dyson JK. Specific considerations for the management of primary biliary cholangitis: are the drug treatment options good enough? Expert Opin Pharmacother 2021;:1-5. [PMID: 34121570 DOI: 10.1080/14656566.2021.1940135] [Reference Citation Analysis]
7 Manne V, Kowdley KV. Obeticholic acid in primary biliary cholangitis: where we stand. Current Opinion in Gastroenterology 2019;35:191-6. [DOI: 10.1097/mog.0000000000000525] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 4.3] [Reference Citation Analysis]
8 Kremer AE, Mayo MJ, Hirschfield G, Levy C, Bowlus CL, Jones DE, Steinberg A, McWherter CA, Choi YJ. Seladelpar improved measures of pruritus, sleep, and fatigue and decreased serum bile acids in patients with primary biliary cholangitis. Liver Int 2021. [PMID: 34403559 DOI: 10.1111/liv.15039] [Reference Citation Analysis]
9 . UEG Week 2018 Poster Presentations. United European Gastroenterol j 2018;6. [DOI: 10.1177/2050640618792819] [Cited by in Crossref: 16] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
10 Kim HP, Lieber SR, Rogers ME, Moon AM, Loiselle M, Walker J, Assis DN, Safer R, Gomel R, Evon DM. A Systematic Review of Patient-Reported Outcomes in Primary Biliary Cholangitis and Primary Sclerosing Cholangitis. Hepatol Commun 2020;4:1502-15. [PMID: 33024919 DOI: 10.1002/hep4.1567] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Sun Q, Wang Q, Feng N, Meng Y, Li B, Luo D, Shang X, Lv J, Monsaf AM, Wang C, Ma X. The expression and clinical significance of serum IL-17 in patients with primary biliary cirrhosis. Ann Transl Med 2019;7:389. [PMID: 31555703 DOI: 10.21037/atm.2019.07.100] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
12 Pantzaris ND, Lord T, Sotheran R, Hutchinson J, Millson C. Nasobiliary Drain Diverted through a Percutaneous Endoscopic Gastrostomy Tube: A Novel Approach to Nasobiliary Drainage. Case Rep Gastroenterol 2021;15:891-7. [PMID: 34720840 DOI: 10.1159/000518057] [Reference Citation Analysis]
13 Martin ML, Stassek L, Blum SI, Joshi AV, Jones D. Development and adaptation of patient-reported outcome measures for patients who experience itch associated with primary biliary cholangitis. J Patient Rep Outcomes 2019;3:2. [PMID: 30645706 DOI: 10.1186/s41687-018-0090-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]